On July 25丨Bellerophon Therapeutics (BLPH.US) plummeted 38% to $0.439. According to US Securities and Exchange Commission documents, the company said it had received a delisting notice from NASDAQ on July 19 and will be removed from the list at the opening of trading on July 28. The company plans to apply to the hearing panel for a hearing; shares will continue to be listed on the NASDAQ until the hearing process is over.
美股异动丨药物开发商Bellerophon Therapeutics暴跌38% 公司收到退市通知
US stock changes丨Drug developer Bellerophon Therapeutics plummeted 38% The company received a delisting notice
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.